Onderzoeker
Patrik Verstreken
- Disciplines (Flanders Institute for Biotechnology):Analyse van next-generation sequence data, Celdood, Gedragsneurowetenschappen
- Disciplines (KU Leuven):Neurologische en neuromusculaire ziekten
- Zie ook: Patrik Verstreken (KU Leuven)
Affiliaties
- Onderzoeksgroep Moleculaire Neurobiologie (VIB-KU Leuven) (Afdeling)
Verantwoordelijke
Vanaf1 jan 2017 → Heden - Laboratorium voor Neuronale Communicatie (VIB-KU Leuven) (Labo)
Verantwoordelijke
Vanaf1 jan 2008 → Heden - Laboratorium voor Neuronale Communicatie (VIB-KU Leuven) (Labo)
Lid
Vanaf1 jan 2017 → Heden - VIB-KU Leuven Center for Brain & Disease Research (Onderzoekscentrum)
Verantwoordelijke
Vanaf1 jan 2017 → Heden - Verstreken Lab (Onderzoeksgroep)
Verantwoordelijke
Vanaf1 jan 2017 → Heden - Departement Menselijke Erfelijkheid (Departement)
Lid
Vanaf1 apr 2009 → 31 dec 2016
Projecten
1 - 10 of 19
- A function for sleep-dependent tau dynamicsVanaf1 apr 2024 → HedenFinanciering: HORIZON.1.2 - Marie Skłodowska-Curie-acties (MSCA)
- Keep your brain cool during a sleepless night (The Branco Weiss Fellowship for Marieke Hoekstra)Vanaf1 nov 2023 → HedenFinanciering: Andere int. instellingen niet elders genoemd
- EMBO Postdoctoral fellowship voor Katrin LindaVanaf1 feb 2023 → HedenFinanciering: EMBL
- Synaptic resilience in Tau-induced neurodegenerationVanaf1 jan 2023 → HedenFinanciering: Andere Eu-programma's en intiatieven
- This grant is to support the work conducted by Patrik Verstreken on project Brain on a Chip Hands- On Training Workshops (VIB) to support hands-on "brain on a chip" trainings for researchers in the Neurodegeneration Challenge Network (NDCN)Vanaf1 nov 2022 → HedenFinanciering: Andere int. instellingen niet elders genoemd
- EMBO Long-term fellowship for Nicolò CarranoVanaf1 mei 2022 → HedenFinanciering: EMBL
- VIB Grant for Verstreken Lab_Period:2022-01-01-2026-12-31Vanaf1 jan 2022 → HedenFinanciering: VOI - Projectmatig onderzoek
- The Parkinson’s Interest Group (PIG) goes live!Vanaf1 aug 2021 → 30 apr 2022Financiering: Andere int. instellingen niet elders genoemd
- Dissecting the link between astrocyte diversity and PD risk” to investigate how neurodegenerative diseases, including Parkinson’s disease, intersect with regional aspects of astrocyte identityVanaf1 jul 2021 → 31 dec 2022Financiering: Andere int. instellingen niet elders genoemd
- Understanding inherited and acquired genetic variation in Parkinson’s disease through single-cell multi-omics analyses: a unique data resourceVanaf1 mrt 2021 → 29 feb 2024Financiering: Buitenl. stichtingen, fondsen e.d. met wet. oogmerk
Publicaties
1 - 10 van 45
- Elevated a-synuclein levels inhibit mitophagic flux.(2024)
Auteurs: Inge Kinnart, Roman Praschberger, Patrik Verstreken
Pagina's: 80 - EndophilinA-dependent coupling between activity-induced calcium influx and synaptic autophagy is disrupted by a Parkinson-risk mutation.(2023)
Auteurs: Adekunle Bademosi, Marianna Decet, Nikolaos Louros, Ella Martin, Wim Versées, Frederic Rousseau, Joost Schymkowitz, Patrik Verstreken
Pagina's: 1402-1422.e13 - Neurodegeneration cell per cell.(2023)
Auteurs: Sriram Balusu, Roman Praschberger, Bart De Strooper, Patrik Verstreken
Pagina's: 767-786 - Parkinsonism mutations in DNAJC6 cause lipid defects and neurodegeneration that are rescued by Synj1.(2023)
Auteurs: Julie Jacquemyn, Benjamin Pavie, Vinoy Vijayan, Ayse Kilic, Nikky Corthout, Patrik Verstreken
Pagina's: 19 - Neuronal identity defines a-synuclein and tau toxicity.(2023)
Auteurs: Roman Praschberger, Natalie Kaempf, Jasper Janssens, Eliana Nachman, Stein Aerts, Patrik Verstreken
Pagina's: 1-14 - Tyrosyl-tRNA synthetase has a noncanonical function in actin bundling.(2023)
Auteurs: Laura Morant, Sven Bervoets, Akram Mokhtarzadeh Khanghahi, Patrik Verstreken, Albena Jordanova
Pagina's: 999 - Synaptic proteostasis in Parkinson's disease.(2022)
Auteurs: Eliana Nachman, Patrik Verstreken
Pagina's: 72-79 - A reference human induced pluripotent stem cell line for large-scale collaborative studies.(2022)
Auteurs: Carles Calatayud Aristoy, Patrik Verstreken, Laurin Heinrich
Pagina's: 1685-1702.e22 - The Alzheimer susceptibility gene BIN1 induces isoform-dependent neurotoxicity through early endosome defects.(2022)
Auteurs: Patrik Verstreken
Pagina's: 4 - Do we still need animals? Surveying the role of animal-free models in Alzheimer's and Parkinson's disease research.(2022)
Auteurs: Bart De Strooper, Patrik Verstreken
Pagina's: e110002
Patenten
1 - 10 van 10
- OLIGONUCLEOTIDES FOR MODULATING SYNAPTOGYRIN-3 EXPRESSION (Inventor)
- TARGETING SYNAPTOGYRIN-3 IN TAUOPATHY TREATMENT (Inventor)
- TARGETING SYNAPTOGYRIN-3 IN TAUOPATHY TREATMENT (Inventor)
- TARGETING SYNAPTOGYRIN-3 IN TAUOPATHY TREATMENT (Inventor)
- TARGETING SYNAPTOGYRIN-3 IN TAUOPATHY TREATMENT (Inventor)
- Compounds for treatment of intractable epilepsy and DOORS syndrome (Inventor)
- Compounds for treatment of intractable epilepsy and DOORS syndrome (Inventor)
- TARGETING SYNAPTOGYRIN-3 IN TAUOPATHY TREATMENT (Inventor)
- Compounds for treatment of intractable epilepsy and DOORS syndrome (Inventor)
- Inhibition of Tau-mediated early synaptic dysfunction (Inventor)